Something big is brewing behind the scenes. A second buy recommendation received from Australia Small Cap Investment today.
I am just wondering what is happening behind the scenes. CAN is being recommended “but” by two independent companies and trading volume was picked up well above the average volume before recommendations released.
Do they know something that we do not know?
Here is a quoting from the report:
“The ASX pot play I’ll show you today was awarded a cannabis import/export license by the federal government in October last year.
It’s backed by the biggest financial players on the planet including HSBC Bank and JP Morgan…
And its biggest shareholder is a $4.7 billion Canadian cannabis juggernaut. If that’s not a vote of confidence that this tiny Aussie pot player is going places…I don’t know what is!
Everything is falling into place for this firm. I think it’s only a matter of time before the share price starts to take flight. My analysis tell me, this one stock alone could help you to a 495% profit starting this year.”
- Forums
- ASX - By Stock
- CAN
- Takeover imminent
Takeover imminent, page-71
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $13.55M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.0¢ | $20.99K | 678.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1079784 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 134706 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1079784 | 0.030 |
7 | 227000 | 0.029 |
3 | 742642 | 0.028 |
5 | 205555 | 0.027 |
3 | 165260 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 134706 | 7 |
0.033 | 519176 | 5 |
0.034 | 83720 | 2 |
0.035 | 110657 | 6 |
0.036 | 145000 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online